Skip to Content
Merck
CN
  • Non-competitive cyclic peptides for targeting enzyme-substrate complexes.

Non-competitive cyclic peptides for targeting enzyme-substrate complexes.

Chemical science (2018-06-15)
T E McAllister, T-L Yeh, M I Abboud, I K H Leung, E S Hookway, O N F King, B Bhushan, S T Williams, R J Hopkinson, M Münzel, N D Loik, R Chowdhury, U Oppermann, T D W Claridge, Y Goto, H Suga, C J Schofield, A Kawamura
ABSTRACT

Affinity reagents are of central importance for selectively identifying proteins and investigating their interactions. We report on the development and use of cyclic peptides, identified by mRNA display-based RaPID methodology, that are selective for, and tight binders of, the human hypoxia inducible factor prolyl hydroxylases (PHDs) - enzymes crucial in hypoxia sensing. Biophysical analyses reveal the cyclic peptides to bind in a distinct site, away from the enzyme active site pocket, enabling conservation of substrate binding and catalysis. A biotinylated cyclic peptide captures not only the PHDs, but also their primary substrate hypoxia inducible factor HIF1-α. Our work highlights the potential for tight, non-active site binding cyclic peptides to act as promising affinity reagents for studying protein-protein interactions.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-HIF-1-alpha Antibody, hydroxyproline (Pro402), from rabbit, purified by affinity chromatography